Market Overview

UPDATE: Sterne Agee Downgrades Comerica to Neutral on Limited Upside

Share:
Related CMA
Why it's Better to Hold BNY Mellon (BK) in Your Portfolio
Why it's Better to Hold BNY Mellon (BK) in Your Portfolio

Sterne Agee reduced its rating on Comerica (NYSE: CMA) from Buy to Neutral and lowered its price target from $36 to $32.

Sterne Agee noted, "We are downgrading the shares to Neutral from Buy despite a valuation slightly below TBVPS. In our view the upside/downside proposition has changed, with the shares still having minimal downside risk, but also less upside potential. We have lowered our FY13/14 estimates by ~4%. For longer-term shareholders the shares still represent a solid holding; our view is the name is less likely to outperform going forward unless something meaningful occurs with interest rates."

Comerica closed at $30.30 on Wednesday.

Latest Ratings for CMA

DateFirmActionFromTo
Jun 2017FBR CapitalUpgradesMarket PerformOutperform
Jan 2017CitigroupDowngradesNeutralSell
Jan 2017JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for CMA
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CMA)

View Comments and Join the Discussion!